acyclovir

NDC 65219-622 · Fresenius Kabi USA, LLC

Generic nameACYCLOVIR

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)ACYCLOVIR SODIUM

Strength50 mg/mL

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

65219-622-10 — 10 VIAL in 1 CARTON (65219-622-10) / 10 mL in 1 VIAL (65219-622-02)

Billed under HCPCS

J0133 — Injection, acyclovir, 5 mg Medicare Part B payment limit (ASP + 6%): $0.05

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9657 — Acyclovir, 0143-9658 — Acyclovir, 55150-154 — Acyclovir Sodium, 55150-155 — Acyclovir Sodium, 63323-325 — acyclovir, 65219-624 — ACYCLOVIR, 68382-048 — ACYCLOVIR, 68382-049 — ACYCLOVIR, 70436-030 — acyclovir, 70771-1383 — ACYCLOVIR, 70771-1384 — ACYCLOVIR, 84549-155 — Acyclovir Sodium

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources